Lupin’s Aurangabad facility receives EIR from USFDA

Lupin’s Aurangabad facility receives EIR from USFDA

by admin- Friday, April 3rd, 2020 04:03:25 PM

Pharma essential Lupin has announced the receipt of the Establishment Inspection Report (EIR) from the USFDA for its Aurangabad, India facility. The inspection for
the ability become finished with the aid of the USFDA between February 10, 2020 and February 14, 2020 and concluded with no observations.

News Updates